Skip to main content
. 2018 Nov 9;19:194. doi: 10.1186/s12881-018-0708-4

Table 3.

Haplotypes of the tested genes concerning the analysed phenotypes in HD patients

Gene Polymorphisms Haplotype Freq. Case, Control Frequencies Chi Square P Value Pcorr Valuea OR (95% CI), p valueb OR (95% CI), p valuec
myocardial infarction = CASES, without myocardial infarction = CONTROLS
LXRA rs2279238_rs7120118 GT 0.693 0.646, 0.705 4.810 0.028 0.078 reference 0.761 (0.596–0.971), 0.028
AC 0.168 0.165, 0.169 0.036 0.849 0.993 1.068 (0.777–1.468), 0.685 0.973 (0.713–1.328), 0.863
GC 0.139 0.190, 0.126 9.791 0.002 0.005* 1.645 (1.202–2.252), 0.002 1.624 (1.194–2.208), 0.002*
rs11039155_rs2279238_rs7120118 GGT 0.692 0.646, 0.704 4.565 0.033 0.098 reference 0.771 (0.602–0.989), 0.040
AAC 0.160 0.157, 0.160 0.033 0.857 1.000 1.064 (0.769–1.472), 0.709 0.976 (0.710–1.342), 0.883
GGC 0.137 0.184, 0.124 8.828 0.003 0.005* 1.598 (1.162–2.198), 0.004 1.580 (1.156–2.159), 0.004*
dyslipidaemia by K/DOQI criteria = CASES, without dyslipidaemia by K/DOQI criteria = CONTROLS
ENHO rs72735260_rs2281997 GC 0.582 0.549, 0.619 8.786 0.003 0.008* reference 0.756 (0.624–0.917), 0.004*
GT 0.278 0.314, 0.238 12.299 5.0E-4 0.001* 1.483 (1.191–1.846), 0.0004 1.471 (1.189–1.819), 0.0004*
TC 0.133 0.128, 0.138 0.434 0.5101 0.773 1.045 (0.785–1.390), 0.7645 0.921 (0.698–1.215), 0.562
atherogenic dyslipidaemia = CASES, without atherogenic dyslipidaemia = CONTROLS
ENHO rs72735260_rs2281997 GC 0.582 0.618, 0.544 9.824 0.002 0.004* reference 1.343 (1.109–1.627), 0.003*
GT 0.278 0.244, 0.314 10.532 0.001 0.004* 0.687 (0.553–0.854), 0.0007 0.704 (0.570–0.869), 0.001*
TC 0.133 0.132, 0.133 0.002 0.968 1.000 0.880 (0.661–1.172), 0.3825 0.994 (0.753–1.312), 0.966
LXRA rs11039155_rs2279238 GG 0.827 0.803, 0.853 7.496 0.0062 0.009* reference 0.714 (0.550–0.927), 0.011*
AA 0.161 0.182, 0.137 6.433 0.0112 0.028* 1.401 (1.079–1.819), 0.0111 1.401 (1.079–1.819), 0.011*
rs2279238_rs7120118 GT 0.693 0.676, 0.711 2.423 0.1196 0.249 reference 0.846 (0.689–1.039), 0.110
AC 0.168 0.190, 0.145 6.363 0.0117 0.029* 1.386 (1.069–1.797), 0.0135 1.391 (1.077–1.796), 0.011*
GC 0.139 0.134, 0.145 0.424 0.5151 0.795 0.978 (0.741–1.291), 0.8776 0.819 (0.699–1.207), 0.541
rs11039155_rs2279238_rs7120118 GGT 0.692 0.676, 0.708 2.094 0.1479 0.416 reference 0.873 (0.709–1.074), 0.199
AAC 0.160 0.180, 0.137 5.942 0.0148 0.023* 1.369 (1.049–1.785), 0.0204 1.384 (1.065–1.798), 0.015*
GGC 0.137 0.129, 0.145 0.917 0.3382 0.750 0.935 (0.706–1.236), 0.6351 0.882 (0.669–1.162), 0.370

Significant P-values are indicated using an asterisk

aThe p-value was calculated using the permutation test and 1000 permutations

bThe most common haplotype was used as the reference

cAll other haplotypes pooled together were used as the reference

Only ENHO and LXRA haplotypes yielded significant results after correction